The ASAC study, Scandinavian multicentre, placebo-controlled, randomized trial, initiated by our group, investigating the role of aspirin as adjuvant after surgery for colorectal liver metastases, is still recruiting patients and has now 300 of 800 patients included (www.asac.no). The trial is funded by Research Council of Norway, Norwegian Cancer Society, and KLINBEFORSK.
EXCALIBUR study; single centre, un-blinded, three-armed randomized trial for patients with high load of colorectal liver metastases, treated with 1)liver transplantation 2)liver resection 3)hepatic artery infusion of chemotherapy. The trial is approved by the Ethical committee and Norwegian Medicinal Agency and will to be initiated in 2021 (www.excaliburstudy.com).
Precision Medicine in Early Diagnostics and Therapy of Biliary Tract Cancer; is a collaborative project between several groups, led by Sheraz Yaqub, started December 2020.
TESLA trial: Liver Transplantation for Non-Resectable Intrahepatic Cholangiocarcinoma: a prospective exploratory trial; this is a collaborative study between several groups at OUH-KIT treating patients with cholangiocarcinoma
CAMINO study: Investigate the value of MRI in assessing CRC liver mets compared to CT scan, and if MRI affects the surgical decision.
Björk D, Carling U, Gilg S, Hasselgren K, Larsen PN, Lindell G, Røsok BI, Sandström P, Sturesson C, Tschuor C, Sparrelid E, Björnsson B(2025) Hyperbilirubinemia does not impair induced liver hypertrophy after portal vein Embolization-a retrospective scandinavian cohort study Eur J Surg Oncol, 51(7), 109995(in press) DOI 10.1016/j.ejso.2025.109995, PubMed 40147207
Bonsdorff A, Kjeseth T, Kirkegård J, de Ponthaud C, Ghorbani P, Wennerblom J, Williamson C, Acher AW, Thillai M, Tarvainen T, Helanterä I, Uutela A, Sirén J, Kokkola A, Sahakyan M, Kleive D, Hagen R, Lund A, Nielsen MF, Vaillant JC, Fristedt R, Biörserud C, Bratlie SO, Tingstedt B, Labori KJet al.(2025) International multicentre validation of the left pancreatectomy pancreatic fistula prediction models and development and validation of the combined DISPAIR-FRS prediction model Br J Surg, 112(3) DOI 10.1093/bjs/znae313, PubMed 40114539
Yaqub S, Busund S, Smedman TM, Syversveen T, Khan A, Solheim JM, Folseraas T, Wiencke K, Lassen K, Dueland S, Line PD(2025) Liver transplantation for locally advanced non-resectable intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: early results from the TESLA trial Br J Surg, 112(3) DOI 10.1093/bjs/znaf054, PubMed 40099404